n-methyl-3,4-methylenedioxyamphetamine has been researched along with selegiline in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Nichols, DE; Sprague, JE | 2 |
| Azmitia, EC; Gu, XF | 1 |
| Johnson, MP; Nichols, DE; Schmidt, CJ; Sprague, JE | 1 |
| Brown, AW; Hrometz, SL; Nichols, DE; Sprague, JE | 1 |
| Forsblad, A; Hashemian, S; Jacobsson, SO; Popova, D | 1 |
1 review(s) available for n-methyl-3,4-methylenedioxyamphetamine and selegiline
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
6 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and selegiline
| Article | Year |
|---|---|
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
Topics: Animals; Brain; Hydroxyindoleacetic Acid; Lipid Peroxidation; Male; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Synaptosomes; Tryptophan Hydroxylase | 1995 |
Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum.
Topics: Animals; Corpus Striatum; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Sodium Chloride | 1995 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Studies on the mechanism of p-chloroamphetamine neurotoxicity.
Topics: Animals; Brain; Clorgyline; Dopamine; Fever; Hydroxyindoleacetic Acid; Indans; Male; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Neurotoxins; p-Chloroamphetamine; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Agents | 1996 |
3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B.
Topics: Cell Line, Tumor; Cell Survival; Choriocarcinoma; Dopamine; Drug Interactions; Female; Fluoxetine; Hallucinogens; Humans; Hydrogen Peroxide; Membrane Glycoproteins; Membrane Transport Proteins; Models, Biological; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Pregnancy; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Plasma Membrane Transport Proteins; Time Factors | 2004 |
Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Survival; Clorgyline; Embryonal Carcinoma Stem Cells; Fluoxetine; Gene Expression; Membrane Potential, Mitochondrial; Mice; Monoamine Oxidase; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Selegiline; Serotonin Plasma Membrane Transport Proteins | 2016 |